COMMUNIQUÉS West-GlobeNewswire

CohBar Co-Founder and Scientific Advisor Dr. David Sinclair Named as one of TIME Magazine’s Health Care 50
08/11/2018
Cited for his groundbreaking work on the underlying metabolic causes of aging MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference
08/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]
Genmab to Present at the Jefferies 2018 London Healthcare Conference
08/11/2018
Media Release Copenhagen, Denmark; November 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company’s CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 2018 London Healthcare [...]
Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
08/11/2018
- New Aegerion loan facility, provided by existing bondholders, strengthens balance sheet and is expected to provide bridge to a potential comprehensive long-term capital restructuring - Company expects to achieve [...]
SELLAS Life Sciences to Provide Third Quarter 2018 Financial Results and Corporate Update on November 15, 2018
08/11/2018
NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Homology Medicines to Present at Stifel Healthcare Conference
08/11/2018
BEDFORD, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present during a fireside chat at the Stifel [...]
Albireo to Present at Investor Conferences in November
08/11/2018
BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018
08/11/2018
MINNEAPOLIS, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
08/11/2018
NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products -- CFN Media
08/11/2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Insmed Announces Changes to its Board of Directors
08/11/2018
—Seasoned Pharmaceutical Executive Elizabeth McKee Anderson Appointed as New Director— —Donald Hayden, Jr. Steps Down as Chairman After 13 Years of Distinguished Service— —Chief Executive Officer Will Lewis Elected [...]
Tabula Rasa HealthCare Acquires Cognify an Integration HealthCare Technology Company
08/11/2018
Delivering optimal business performance and outcomes through integrated technology services to senior care organizations and PACE MOORESTOWN, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ [...]
Misonix to Participate in Three Upcoming Investor Conferences
08/11/2018
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
CFN Media's Exclusive Interview with Pascal Biosciences
08/11/2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Align Technology Announces $50 Million Accelerated Stock Repurchase Program
08/11/2018
SAN JOSE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced that it has entered into an accelerated stock repurchase agreement ("ASR") with Morgan Stanley & Co. LLC ("Morgan [...]
PSIQ Acquires Exclusive Distribution Rights to Cheech & Chong Mens Grooming Products With Hemp in the United States and Israel
08/11/2018
SUNRISE, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) through its operating subsidiary Elite Products International Inc. is pleased to announce it has acquired the EXCLUSIVE brick [...]
Hemostemix Announces Important Manufacturing Process Refinements
08/11/2018
CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that is has completed refinements to its manufacturing [...]
First Choice Healthcare Solutions Reports Third Quarter 2018 Results and Update on Strategic Initiatives
08/11/2018
MELBOURNE, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company") , a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
08/11/2018
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that, despite the catastrophic events [...]

Pages